Table 4.
Variable | RMTC patients | PMTC patients | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
PET/CT results | 2.154 (1.129–4.110) | 0.020 | 3.006 (1.010–8.948) | 0.048 | 0.999 (0.307–3.253) | 0.998 | – | – |
MTV | 1.012 (1.005–1.018) | 0.001 | 1.016 (1.002–1.030) | 0.021 | 1.002 (1.001–1.003) | 0.007 | 1.002 (1.000–1.004) | 0.041 |
SUVmax | 1.032 (0.996–1.069) | 0.086 | 0.984 (0.908–1.066) | 0.686 | 0.998 (0.949–1.050) | 0.947 | – | – |
SUVmean | 1.137 (0.978–1.321) | 0.094 | 0.863 (0.596–1.249) | 0.434 | 1.119 (0.887–1.412) | 0.343 | – | – |
SMTC and HMTC | 3.220 (0.990–10.479) | 0.052 | 2.595 (0.785–8.580) | 0.118 | 0.709 (0.251–2.003) | 0.516 | – | – |
Stage | 1.100 (0.957–1.265) | 0.179 | – | – | 1.057 (0.830–1.347) | 0.654 | – | – |
bCt | 1.000 (1.000–1.000) | 0.036 | 1.000 (1.000–1.000) | 0.316 | 1.000 (1.000–1.000) | 0.054 | 1.000 (1.000–1.000) | 0.711 |
Age | 1.004 (0.984–1.024) | 0.699 | – | – | 1.034 (1.004–1.065) | 0.026 | 1.039 (1.008–1.071) | 0.014 |
Gender | 0.811 (0.442–1.488) | 0.498 | – | – | 0.739 (0.390–1.400) | 0.353 | – | – |
bCt, basal calcitonin; HMTC, hereditary MTC; MTV, metabolic tumor volume; PMTC, primary MTC; RMTC, recurrent MTC; SMTC, sporadic MTC; SUVmax, maximum standardized uptake value; SUVmean, mean standardized uptake value; –, not determined.